ATE533493T1 - Schäumende pharmazeutische zusammensetzungen und verfahren zur behandlung einer erkrankung - Google Patents

Schäumende pharmazeutische zusammensetzungen und verfahren zur behandlung einer erkrankung

Info

Publication number
ATE533493T1
ATE533493T1 AT04753550T AT04753550T ATE533493T1 AT E533493 T1 ATE533493 T1 AT E533493T1 AT 04753550 T AT04753550 T AT 04753550T AT 04753550 T AT04753550 T AT 04753550T AT E533493 T1 ATE533493 T1 AT E533493T1
Authority
AT
Austria
Prior art keywords
foamable
disease
treating
methods
novel
Prior art date
Application number
AT04753550T
Other languages
English (en)
Inventor
Karl Popp
Edward Yuhas
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33450867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533493(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Application granted granted Critical
Publication of ATE533493T1 publication Critical patent/ATE533493T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT04753550T 2003-05-28 2004-05-27 Schäumende pharmazeutische zusammensetzungen und verfahren zur behandlung einer erkrankung ATE533493T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/445,487 US7186416B2 (en) 2003-05-28 2003-05-28 Foamable pharmaceutical compositions and methods for treating a disorder
PCT/US2004/016733 WO2004105702A2 (en) 2003-05-28 2004-05-27 Foamable pharmaceutical compositions and methods for treating a disorder

Publications (1)

Publication Number Publication Date
ATE533493T1 true ATE533493T1 (de) 2011-12-15

Family

ID=33450867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04753550T ATE533493T1 (de) 2003-05-28 2004-05-27 Schäumende pharmazeutische zusammensetzungen und verfahren zur behandlung einer erkrankung

Country Status (15)

Country Link
US (2) US7186416B2 (de)
EP (1) EP1633368B1 (de)
JP (1) JP4871728B2 (de)
KR (1) KR101141220B1 (de)
CN (1) CN1794998A (de)
AT (1) ATE533493T1 (de)
AU (1) AU2004242963B2 (de)
BR (1) BRPI0410721A (de)
CA (1) CA2527499C (de)
ES (1) ES2377064T3 (de)
IL (1) IL172082A0 (de)
MX (1) MXPA05012842A (de)
PL (1) PL1633368T3 (de)
WO (1) WO2004105702A2 (de)
ZA (1) ZA200510388B (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6389455B1 (en) * 1998-09-22 2002-05-14 Richard C. Fuisz Method and apparatus for bouncing electronic messages
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
AU2003279493B2 (en) 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
KR20060113907A (ko) 2003-09-29 2006-11-03 에테나 헬스케어 인코포레이티드 높은 알코올 함량의 겔-유사 및 포옴 조성물
ES2552936T3 (es) 2003-12-12 2015-12-03 Otic Pharma Ltd. Composiciones para el tratamiento del desordenes en el oído y métodos para el uso de los mismos
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
WO2005115336A2 (en) * 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
ATE446412T1 (de) * 2004-07-06 2009-11-15 Int Paper Co Papiersubstrate mit antimikrobieller verbindung sowie herstellungs- und anwendungsverfahren dafür
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060137684A1 (en) * 2004-12-01 2006-06-29 Celeste Evans Compositions and methods of treating irritation and kit therefor
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
CN103417388A (zh) 2005-03-07 2013-12-04 戴博全球保健有限公司 含有有机硅表面活性剂的高醇含量发泡组合物
MX2007014101A (es) 2005-05-09 2009-02-13 Foamix Ltd Vehiculo espumable y composiciones farmaceuticas del mismo.
CA2611147C (en) 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Topical emulsion formulation
US20100154146A1 (en) 2008-07-02 2010-06-24 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US8846154B2 (en) 2005-06-07 2014-09-30 S.C. Johnson & Son, Inc. Carpet décor and setting solution compositions
US7651990B2 (en) 2005-06-13 2010-01-26 3M Innovative Properties Company Foamable alcohol compositions comprising alcohol and a silicone surfactant, systems and methods of use
US8778369B2 (en) * 2005-07-29 2014-07-15 Delaval Holding Ab Barrier film-forming compositions and methods of use
US20070027119A1 (en) * 2005-07-29 2007-02-01 Ahmed Fahim U Antibacterial composition and method of use
EP2100601B1 (de) 2005-10-24 2012-06-27 Precision Dermatology, Inc. Topische pharmazeutische Schaumzusammensetzung
PL2206494T3 (pl) 2006-03-31 2016-06-30 Stiefel Res Australia Pty Ltd Spienialny żel zawiesinowy
PT2494959E (pt) * 2006-07-05 2015-02-20 Foamix Pharmaceuticals Ltd Veículo formador de espuma de ácido dicarboxílico e suas composições farmacêuticas
WO2008008397A2 (en) 2006-07-14 2008-01-17 Stiefel Research Australia Pty Ltd Fatty acid pharmaceutical foam
AU2007275815A1 (en) * 2006-07-18 2008-01-24 Wirra Ip Pty. Ltd. Immune response modifier formulations
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
GB2443162B (en) * 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
GB2443161B (en) * 2006-10-28 2011-03-23 Nupharm Lab Ltd Clobetasol spray
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP1986473B1 (de) * 2007-04-03 2017-01-25 Tsinghua University Organische elektrolumineszente vorrichtung
FR2915097B1 (fr) * 2007-04-18 2012-09-28 Fabre Pierre Dermo Cosmetique Mousse antifongique a base de ciclopiroxolamine et de pyrithione de zinc et ses applications medicales et cosmetiques.
BRPI0811071A2 (pt) * 2007-05-04 2014-09-23 The Procter & Gamble Company Produtos, composições microbicidas, e métodos de uso
GB0712308D0 (en) * 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
DE102007039954A1 (de) * 2007-08-23 2009-02-26 Henkel Ag & Co. Kgaa Reduktive Entfärbung keratinhaltiger Fasern
US8802060B2 (en) * 2007-10-01 2014-08-12 Colgate-Palmolive Company Foamable fluoride oral care composition
WO2009084020A2 (en) * 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
EP2242476A2 (de) 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US20110224312A1 (en) * 2008-11-17 2011-09-15 Wayne State University Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
EP2343300A1 (de) * 2009-12-05 2011-07-13 Cognis IP Management GmbH Anionische Isosorbidderivate und ihre Verwendung (II)
US8802058B2 (en) * 2010-04-19 2014-08-12 Gelmed, Llc Pharmaceutical compositions and methods for administering the same
EP2672968A4 (de) * 2010-10-26 2016-07-13 Quinnova Pharmaceuticals Inc Econazolzusammensetzung und behandlungsverfahren damit
CA2852210C (en) 2010-10-26 2019-04-02 Quinnova Pharmaceuticals, Inc. Composition and method for treating wounds
IT1402786B1 (it) * 2010-11-19 2013-09-18 Fidia Farmaceutici Composizioni farmaceutiche ad attivita' antibatterica e cicatrizzante
US9089129B2 (en) 2011-10-07 2015-07-28 American Sterilizer Company Non-aerosol foaming alcohol hand sanitizer
MX2014006453A (es) * 2011-11-30 2014-09-01 Basf Se Composicion para la disolucion y/o inhibicion del deposito de incrustaciones sobre una superficie de un sistema.
CN102641283B (zh) * 2012-04-07 2013-05-08 张红 一种治疗头屑的药物及其制备方法
EP2906946A1 (de) 2012-10-09 2015-08-19 The Procter & Gamble Company Verfahren zur identifikation oder bewertung nützlicher wirkstoffe und zusammensetzungen damit
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
ES2658995T3 (es) 2012-12-26 2018-03-13 Otic Pharma Ltd. Composiciones farmacéuticas óticas espumables
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
EP3020392A4 (de) * 2013-07-11 2016-12-28 Pola Pharma Inc Schäumende zusammensetzung zur äusseren anwendung
CN104032590A (zh) * 2014-05-14 2014-09-10 江苏金秋弹性织物有限公司 一种活性炭-纳米银协同抗菌织带的染色加工工艺
AU2015368402A1 (en) * 2014-12-24 2017-07-27 Pola Pharma Inc. External composition for screen foamers
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
MX375152B (es) * 2015-12-15 2025-03-06 Therapeutics Inc Composición de espuma de halobetasol y método de uso de la misma.
CN105486778B (zh) * 2016-01-25 2017-11-03 齐炼文 诊断区分稳定型心绞痛和急性冠脉综合征的代谢标志物
BR112018071523B1 (pt) 2016-04-20 2022-11-01 S.C. Johnson & Son, Inc Composição antimicrobiana aquosa
BR112018073125B1 (pt) 2016-05-11 2022-09-13 Bayer Healthcare Llc Formulação, métodos para preparar uma formulação espumável e para usar uma formulação espumante, e, embalagem pressurizada
AU2017263532B2 (en) 2016-05-11 2022-02-24 Beiersdorf Ag Whipped formulations
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2018209163A1 (en) 2017-05-11 2018-11-15 Bayer Healthcare Llc. Gel formulations
EP3641725A1 (de) 2017-06-23 2020-04-29 The Procter and Gamble Company Zusammensetzung und verfahren zur verbesserung der erscheinung der haut
JP2021530447A (ja) 2018-07-03 2021-11-11 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 皮膚状態の治療方法
WO2020044223A1 (en) * 2018-08-28 2020-03-05 Glenmark Pharmaceuticals Limited Container system and pharmaceutical foam composition comprising betamethasone
WO2021189226A1 (en) 2020-03-24 2021-09-30 The Procter & Gamble Company Methods for testing skin samples
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4838286A (de) * 1971-09-18 1973-06-05
US4018918A (en) 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
US4141472A (en) * 1976-07-19 1979-02-27 Spitzer Joseph G Aerosol container with gas-permeable membrane
US4141417A (en) 1977-09-09 1979-02-27 Institute Of Gas Technology Enhanced oil recovery
US4420484A (en) 1979-08-13 1983-12-13 Sterling Drug Inc. Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof
JPH0696522B2 (ja) * 1983-10-24 1994-11-30 ロクリ− サ−ヴイシズ プロプライエタリ− リミテツド 起泡型生物致死組成物
EP0190158A1 (de) 1984-06-21 1986-08-13 Soltec Research Pty. Ltd. Aerosolerzeugnis
US5002680A (en) 1985-03-01 1991-03-26 The Procter & Gamble Company Mild skin cleansing aerosol mousse with skin feel and moisturization benefits
US4806262A (en) 1985-08-14 1989-02-21 The Procter & Gamble Company Nonlathering cleansing mousse with skin conditioning benefits
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
JPS62273912A (ja) * 1986-05-21 1987-11-28 Kao Corp 人体塗布用エアゾ−ル剤
US5385938B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of using glycolic acid for treating wrinkles
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US4847068A (en) 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
US4885354A (en) 1987-10-29 1989-12-05 Ciba-Geigy Corporation Epoxy resin compositions
US5143717A (en) 1987-12-30 1992-09-01 Code Blue Medical Corporation Burn foam and delivery system
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
US5110809A (en) 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
JP2903708B2 (ja) 1989-03-17 1999-06-14 大正製薬株式会社 外用エアゾール剤
WO1991001712A1 (en) * 1989-07-28 1991-02-21 Hisamitsu Pharmaceutical Co., Inc. Foamed aerosol preparation
IL95952A0 (en) 1989-10-19 1991-07-18 Sterling Drug Inc Aerosol composition for topical medicament
WO1992004419A1 (en) 1990-09-03 1992-03-19 Soltec Research Pty. Ltd. A concentrated aerosol space spray
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
US5167950A (en) 1991-03-28 1992-12-01 S. C. Johnson & Son High alcohol content aerosol antimicrobial mousse
FR2677369B1 (fr) 1991-06-05 1994-09-16 Promotion Rech Innovation Tec Mousse aerosol.
DE4129756C2 (de) 1991-09-04 1995-06-29 Mannesmann Ag Metallurgisches Gefäß für eine Gleichstromlichtbogeneinrichtung
GB2260079B (en) * 1991-10-01 1995-08-09 American Cyanamid Co Pharmaceutical composition containing felbinac
US5211317A (en) 1992-06-18 1993-05-18 Diamond George Bernard Low pressure non-barrier type, valved dispensing can
ZA94170B (en) 1993-01-20 1995-03-15 Soltec Res Pty Ltd Ectoparasiticidal formulation
US5570296A (en) 1994-03-30 1996-10-29 Apple Computer, Inc. System and method for synchronized presentation of video and audio signals
US5679324A (en) 1994-07-08 1997-10-21 The Procter & Gamble Co. Aerosol foamable fragrance composition
US5776430A (en) 1994-11-01 1998-07-07 Calgon Vestal, Inc. Topical antimicrobial cleanser containing chlorhexidine gluconate and alcohol
JPH08175982A (ja) * 1994-12-21 1996-07-09 Lederle Japan Ltd ４−ビフェニリル酢酸組成液
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
SK284448B6 (sk) 1995-04-14 2005-04-01 Glaxo Wellcome Inc. Merací dávkovací inhalátor
EP0738510A3 (de) 1995-04-20 2005-12-21 L'oreal Verwendung eines HMG-CoA-Reduktase Inhibitors als Hautalterungschutzmittel und als Anti-Aknemittel. Zusammensetzung enthaltend mindestens einen HMG-CoA-Reduktase Inhibitor und mindestens einen Wirkstoff mit abschuppenden Eigenschaften
FR2740685B1 (fr) 1995-11-08 1998-01-23 Pf Medicament Composition pharmaceutique topique moussante pour le traitement des dermatoses, induites par pityrosporum ovale
US5788155A (en) 1996-06-28 1998-08-04 S. C. Johnson & Son, Inc. Air freshener dispenser device with dual cartridge capacity
DE19631221C2 (de) 1996-08-02 1999-07-01 Beiersdorf Ag Schaumförmige Lichtschutzzubereitungen mit einem Gehalt an wasserlöslichen Lichtschutzfiltersubstanzen und grenzflächenaktiven Substanzen
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
EP0993827A4 (de) 1997-06-13 2006-07-05 Taisho Pharmaceutical Co Ltd Aerosole
GB2327344A (en) 1997-07-18 1999-01-27 Ninh Thuy On Pharmaceutical compositions containing phenytoin and either an azole anti-fungal/anti-bacterial agent and/or a silver salt for topical application
US5965500A (en) 1997-07-24 1999-10-12 Levers Brothers Company, Division Of Conopco, Inc. Stable liquid composition comprising high levels of emollients
AUPO983897A0 (en) * 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
PL342648A1 (en) 1998-02-02 2001-06-18 Boehringer Ingelheim Vetmed Veterinary application of a combination of active agent consisting of bactericides and terpene containing plant extracts
US6030931A (en) 1998-02-03 2000-02-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Foaming cleansing skin product
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6264964B1 (en) 1999-04-14 2001-07-24 Conopco, Inc. Foaming cosmetic products
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
US6547063B1 (en) 2000-10-10 2003-04-15 The Procter & Gamble Company Article for the delivery of foam products
FR2820038B1 (fr) * 2001-01-29 2004-07-02 Dermaconcept Jmc Composition dermatologique a usage veterinaire comprenant une base sphingoide
HU0104790D0 (en) 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
EA009031B1 (ru) 2003-01-24 2007-10-26 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
WO2009101712A1 (ja) * 2008-02-14 2009-08-20 Nagoya Oilchemical Co., Ltd. 吸音性表皮材、及びそれを用いた吸音材

Also Published As

Publication number Publication date
WO2004105702A2 (en) 2004-12-09
IL172082A0 (en) 2009-02-11
AU2004242963A1 (en) 2004-12-09
US20070059253A1 (en) 2007-03-15
KR20060023972A (ko) 2006-03-15
AU2004242963B2 (en) 2009-05-28
CN1794998A (zh) 2006-06-28
CA2527499C (en) 2012-01-24
EP1633368A2 (de) 2006-03-15
ES2377064T3 (es) 2012-03-22
US7186416B2 (en) 2007-03-06
CA2527499A1 (en) 2004-12-09
MXPA05012842A (es) 2006-05-17
PL1633368T3 (pl) 2012-04-30
BRPI0410721A (pt) 2006-06-20
US20040241099A1 (en) 2004-12-02
KR101141220B1 (ko) 2012-05-07
US7829107B2 (en) 2010-11-09
JP4871728B2 (ja) 2012-02-08
EP1633368B1 (de) 2011-11-16
WO2004105702A3 (en) 2005-05-06
EP1633368A4 (de) 2007-03-14
JP2007500235A (ja) 2007-01-11
ZA200510388B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
ATE533493T1 (de) Schäumende pharmazeutische zusammensetzungen und verfahren zur behandlung einer erkrankung
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
KR20180088415A (ko) 국소적 막형성 스프레이
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
MX2009002893A (es) Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
WO2008054544A3 (en) Method for delivery across the blood brain barrier
BR0109875A (pt) Tratamento de doenças respiratórias
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
BRPI0409427A (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
WO2005046593A3 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases.
WO2004043378A3 (en) Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
ATE521343T1 (de) Im mund zerfallende zusammensetzungen von rasagilin
TW200509998A (en) Controlled release of highly soluble agents
ATE248511T1 (de) Zusammensetzung zur zielortspezifischen verabreichung eines medikamentes und verfahren zur anwendung
GB2446341A (en) Method and system for transdermal drug delivery
WO2005020959A3 (en) Novel drug compositions and dosage forms of topiramate
BRPI0408113A (pt) métodos para tratar ou prevenir um distúrbio do sistema nervoso central, para controlar um distúrbio do sistema nervoso central e para reduzir ou evitar um efeito adverso associado com a administração de um ingrediente ativo secundário em um paciente que sofre de um distúrbio do sistema nervoso central, e, composição farmacêutica
AR018376A1 (es) Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
ATE259223T1 (de) Pharmazeutische zusammensetzung die einen no donor enthält und dessen therapeutische anwendung
WO2005065372A3 (en) Methods and compositions using thalidomide for the treatment and management of central nervous system disorders or diseases
UA23763A (uk) Спосіб одержаhhя лікувальhого засобу при захворюваhhях, що супроводжуються порушеhhям фуhкцій цеhтральhої hервової системи
ATE477021T1 (de) 1,3,5-triazepin-dionen zur behandlung von malaria
MX2025004091A (es) Administracion transdermica de dextrometorfano